Biotechnology
The Biotechnology industry has a total of 596 stocks, with a combined market cap of $1.28 trillion and total revenue of $123.27 billion.
Market Cap
1.28T
Revenue
123.27B
Profits
-34.07B
PE Ratio
n/a
Profit Margin
-27.64%
Dividend Yield
0.04%
596 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 135.44B | -0.67% | 1,511,472 | 12.95B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 96.11B | 0.56% | 933,388 | 16.90B |
| 3 | MRNA | Moderna, Inc. | 83.68B | -3.93% | 8,277,038 | 2.53B |
| 4 | ARGX | argenx SE | 58.86B | -0.36% | 418,653 | 5.92B |
| 5 | ONC | BeOne Medicines AG | 47.21B | 0.48% | 235,009 | 6.45B |
| 6 | RPRX | Royalty Pharma plc | 39.40B | 0.22% | 2,803,238 | 2.62B |
| 7 | RVMD | Revolution Medicines, Inc. | 35.19B | -2.50% | 2,689,798 | 197.56M |
| 8 | GMAB | Genmab A/S | 32.90B | 0.76% | 3,322,436 | 4.30B |
| 9 | ROIV | Roivant Sciences Ltd. | 28.05B | 0.26% | 8,472,721 | 41.08M |
| 10 | INSM | Insmed Incorporated | 26.73B | -0.83% | 2,397,572 | 1.52B |
| 11 | INCY | Incyte Corporation | 24.27B | -0.98% | 2,247,052 | 6.01B |
| 12 | BNTX | BioNTech SE | 21.04B | -0.47% | 1,091,006 | 2.75B |
| 13 | ALNY | Alnylam Pharmaceuticals, Inc. | 20.96B | -2.02% | 2,050,015 | 5.01B |
| 14 | ASND | Ascendis Pharma A/S | 17.79B | -0.20% | 586,801 | 1.37B |
| 15 | EXEL | Exelixis, Inc. | 16.71B | 2.09% | 2,818,820 | 2.50B |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 15.45B | 0.39% | 499,450 | 4.72B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 14.96B | -0.72% | 2,812,128 | 945.54M |
| 18 | TECH | Bio-Techne Corporation | 11.41B | -0.22% | 5,694,130 | 1.23B |
| 19 | BMRN | BioMarin Pharmaceutical Inc. | 11.33B | 0.90% | 2,251,988 | 3.66B |
| 20 | HALO | Halozyme Therapeutics, Inc. | 10.94B | -0.55% | 2,041,007 | 1.80B |
| 21 | MTRI | Mentari Therapeutics, Inc. | 10.52B | -11.93% | 171,045 | - |
| 22 | KYMR | Kymera Therapeutics, Inc. | 10.37B | -3.44% | 855,081 | 102.24M |
| 23 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.80B | -0.46% | 364,671 | 1.43B |
| 24 | PCVX | Vaxcyte, Inc. | 9.40B | -3.59% | 1,107,703 | - |
| 25 | SYRE | Spyre Therapeutics, Inc. | 8.91B | -5.60% | 1,109,260 | - |
| 26 | KRYS | Krystal Biotech, Inc. | 8.85B | 0.22% | 164,433 | 470.03M |
| 27 | TGTX | TG Therapeutics, Inc. | 8.79B | -0.08% | 1,714,250 | 897.76M |
| 28 | SMMT | Summit Therapeutics Inc. | 8.53B | -9.73% | 13,171,551 | - |
| 29 | PRAX | Praxis Precision Medicines, Inc. | 8.53B | -1.68% | 836,922 | 7.46M |
| 30 | PTGX | Protagonist Therapeutics, Inc. | 8.14B | -0.13% | 583,063 | 551.69M |
| 31 | RYTM | Rhythm Pharmaceuticals, Inc. | 8.08B | 8.49% | 2,597,243 | 280.75M |
| 32 | CORT | Corcept Therapeutics Incorporated | 7.67B | 1.23% | 985,527 | 963.65M |
| 33 | ABVX | ABIVAX Société Anonyme | 7.25B | -1.81% | 1,375,464 | 5.33M |
| 34 | CYTK | Cytokinetics, Incorporated | 7.20B | -2.86% | 2,712,185 | 113.29M |
| 35 | AXSM | Axsome Therapeutics, Inc. | 7.15B | -0.77% | 518,769 | 865.27M |
| 36 | CGON | CG Oncology, Inc. | 7.05B | -6.89% | 3,160,990 | 6.17M |
| 37 | TWST | Twist Bioscience Corporation | 7.02B | 6.63% | 2,070,077 | 459.43M |
| 38 | IMVT | Immunovant, Inc. | 6.87B | -0.21% | 926,704 | - |
| 39 | IBRX | ImmunityBio, Inc. | 6.66B | 4.68% | 11,508,018 | 182.57M |
| 40 | ORKA | Oruka Therapeutics, Inc. | 6.53B | -2.94% | 780,186 | - |
| 41 | BLTE | Belite Bio, Inc | 6.35B | -2.98% | 94,763 | - |
| 42 | KOD | Kodiak Sciences Inc. | 6.32B | -3.90% | 820,646 | - |
| 43 | ARWR | Arrowhead Pharmaceuticals, Inc. | 6.08B | -2.76% | 3,703,613 | 450.82M |
| 44 | MIRM | Mirum Pharmaceuticals, Inc. | 6.00B | 0.40% | 377,665 | 670.78M |
| 45 | LGND | Ligand Pharmaceuticals Incorporated | 5.88B | -2.62% | 293,627 | 253.83M |
| 46 | CAI | Caris Life Sciences, Inc. | 5.72B | -5.05% | 4,901,076 | 1.05B |
| 47 | SRRK | Scholar Rock Holding Corporation | 5.50B | 1.21% | 2,330,639 | 570.00K |
| 48 | MANE | Veradermics, Incorporated | 5.30B | -1.88% | 401,321 | - |
| 49 | PTCT | PTC Therapeutics, Inc. | 5.04B | -1.00% | 1,122,336 | 1.16B |
| 50 | TVTX | Travere Therapeutics, Inc. | 4.91B | 2.82% | 1,399,276 | 651.03M |
| 51 | DNTH | Dianthus Therapeutics, Inc. | 4.90B | -2.87% | 563,972 | 2.72M |
| 52 | ERAS | Erasca, Inc. | 4.87B | -8.07% | 8,792,191 | - |
| 53 | COGT | Cogent Biosciences, Inc. | 4.85B | 1.49% | 3,363,374 | - |
| 54 | EWTX | Edgewise Therapeutics, Inc. | 4.60B | -3.75% | 1,401,194 | - |
| 55 | IONS | Ionis Pharmaceuticals, Inc. | 4.49B | -3.75% | 4,485,239 | 960.09M |
| 56 | DFTX | Definium Therapeutics, Inc. | 4.02B | -2.59% | 1,937,177 | - |
| 57 | SLS | SELLAS Life Sciences Group, Inc. | 3.90B | 156.36% | 121,290,298 | - |
| 58 | CRSP | CRISPR Therapeutics AG | 3.89B | -0.54% | 4,109,496 | 25.17M |
| 59 | TARS | Tarsus Pharmaceuticals, Inc. | 3.86B | -0.61% | 542,218 | 682.20M |
| 60 | XENE | Xenon Pharmaceuticals Inc. | 3.81B | -1.22% | 2,396,354 | 7.50M |
| 61 | TNGX | Tango Therapeutics, Inc. | 3.75B | -8.52% | 2,058,206 | 53.81M |
| 62 | RLAY | Relay Therapeutics, Inc. | 3.64B | -4.63% | 2,569,179 | 10.35M |
| 63 | ABCL | AbCellera Biologics Inc. | 3.60B | -0.81% | 2,695,640 | 67.85M |
| 64 | PBLS | Parabilis Medicines, Inc. | 3.54B | -0.70% | 480,475 | 2.26M |
| 65 | IRON | Disc Medicine, Inc. | 3.49B | -0.03% | 520,620 | - |
| 66 | IOVA | Iovance Biotherapeutics, Inc. | 3.48B | -0.26% | 8,842,404 | 378.98M |
| 67 | ARQT | Arcutis Biotherapeutics, Inc. | 3.46B | 0.66% | 1,315,540 | 508.68M |
| 68 | ELVN | Enliven Therapeutics, Inc. | 3.45B | -1.62% | 652,268 | - |
| 69 | VKTX | Viking Therapeutics, Inc. | 3.43B | 0.30% | 4,577,484 | - |
| 70 | VRDN | Viridian Therapeutics, Inc. | 3.41B | 0.87% | 1,838,166 | 26.31M |
| 71 | ACAD | Acadia Pharmaceuticals Inc. | 3.17B | -1.87% | 1,535,350 | 1.20B |
| 72 | LEGN | Legend Biotech Corporation | 3.12B | 0.75% | 3,030,025 | 1.36B |
| 73 | TLX | Telix Pharmaceuticals Limited | 3.05B | -0.73% | 249,301 | 890.79M |
| 74 | ADMA | ADMA Biologics, Inc. | 3.02B | 1.19% | 2,948,307 | 519.15M |
| 75 | DYN | Dyne Therapeutics, Inc. | 3.00B | -4.07% | 2,058,012 | - |
| 76 | VCEL | Vericel Corporation | 2.95B | 0.70% | 555,308 | 324.17M |
| 77 | DNLI | Denali Therapeutics Inc. | 2.89B | -0.44% | 1,130,978 | 21.38M |
| 78 | CELC | Celcuity Inc. | 2.85B | -4.23% | 2,544,062 | - |
| 79 | IDYA | IDEAYA Biosciences, Inc. | 2.65B | -9.75% | 2,044,658 | 36.54M |
| 80 | ZLAB | Zai Lab Limited | 2.65B | 0.26% | 690,592 | 441.73M |
| 81 | MBX | MBX Biosciences, Inc. | 2.64B | -0.04% | 356,068 | - |
| 82 | XNCR | Xencor, Inc. | 2.59B | -2.54% | 1,616,765 | 200.49M |
| 83 | RCUS | Arcus Biosciences, Inc. | 2.36B | -2.79% | 1,919,155 | 100.00M |
| 84 | NAMS | NewAmsterdam Pharma Company N.V. | 2.33B | -0.36% | 1,364,419 | 25.94M |
| 85 | PHVS | Pharvaris N.V. | 2.27B | -0.49% | 241,401 | - |
| 86 | LKFT | Lakefront Biotherapeutics NV | 2.22B | -1.15% | 241,178 | 1.13B |
| 87 | CLDX | Celldex Therapeutics, Inc. | 2.20B | -1.92% | 520,651 | 158.00K |
| 88 | PVLA | Palvella Therapeutics, Inc. | 2.11B | -0.17% | 212,092 | - |
| 89 | AUPH | Aurinia Pharmaceuticals Inc. | 2.06B | -0.52% | 833,655 | 321.74M |
| 90 | BEAM | Beam Therapeutics Inc. | 2.06B | -1.38% | 4,127,651 | 146.64M |
| 91 | IMNM | Immunome, Inc. | 2.03B | -2.44% | 1,027,488 | 4.02M |
| 92 | BHVN | Biohaven Ltd. | 2.00B | -4.06% | 1,569,004 | - |
| 93 | HRMY | Harmony Biosciences Holdings, Inc. | 1.94B | 0.15% | 607,331 | 989.36M |
| 94 | TRVI | Trevi Therapeutics, Inc. | 1.93B | 1.66% | 1,728,748 | - |
| 95 | SEPN | Septerna, Inc. | 1.90B | -3.96% | 271,758 | 96.27M |
| 96 | VERA | Vera Therapeutics, Inc. | 1.89B | -2.86% | 1,222,087 | 10.28M |
| 97 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.89B | -1.62% | 1,609,034 | 213.00M |
| 98 | FTRE | Fortrea Holdings Inc. | 1.89B | -1.01% | 2,118,288 | 2.67B |
| 99 | ZBIO | Zenas BioPharma, Inc. | 1.88B | -0.64% | 524,652 | 11.00M |
| 100 | REPL | Replimune Group, Inc. | 1.87B | -8.03% | 2,434,491 | - |
| 101 | TRAX | First Tracks Biotherapeutics, Inc. | 1.83B | -6.42% | 586,462 | - |
| 102 | COAG | Hemab Therapeutics Holdings, Inc. | 1.83B | 0.00% | 281,495 | - |
| 103 | MAZE | Maze Therapeutics, Inc. | 1.80B | -3.04% | 601,753 | 20.00M |
| 104 | AGIO | Agios Pharmaceuticals, Inc. | 1.79B | -0.86% | 664,573 | 140.84M |
| 105 | ZYME | Zymeworks Inc. | 1.78B | -2.31% | 569,911 | 265.97M |
| 106 | LYCA | Lycia Therapeutics, Inc. | 1.78B | 8.07% | 496,267 | 4.44M |
| 107 | STOK | Stoke Therapeutics, Inc. | 1.73B | -0.83% | 550,079 | 28.21M |
| 108 | RARE | Ultragenyx Pharmaceutical Inc. | 1.70B | 5.03% | 5,592,538 | 730.00M |
| 109 | RXRX | Recursion Pharmaceuticals, Inc. | 1.70B | -6.37% | 41,021,204 | 68.23M |
| 110 | VIR | Vir Biotechnology, Inc. | 1.58B | -3.44% | 3,483,984 | 302.80M |
| 111 | KLRA | Kailera Therapeutics, Inc. | 1.58B | -2.94% | 511,123 | - |
| 112 | SRPT | Sarepta Therapeutics, Inc. | 1.58B | -2.38% | 2,403,137 | 1.96B |
| 113 | MESO | Mesoblast Limited | 1.57B | -4.34% | 262,084 | 120.25M |
| 114 | NRIX | Nurix Therapeutics, Inc. | 1.56B | -3.33% | 2,225,314 | 701.94M |
| 115 | PGEN | Precigen, Inc. | 1.54B | -0.23% | 4,373,014 | 156.94M |
| 116 | BRVE | Braveheart Bio, Inc. | 1.53B | -3.64% | 971,285 | - |
| 117 | WWB | Windward Bio Group AG | 1.50B | -14.25% | 241,424 | - |
| 118 | KRSA | Korsana Biosciences, Inc. | 1.48B | -0.55% | 202,248 | - |
| 119 | ADRX | ADARx Pharmaceuticals, Inc. | 1.48B | -1.29% | 696,893 | 6.13M |
| 120 | URGN | UroGen Pharma Ltd. | 1.47B | 6.30% | 2,771,748 | 250.25M |
| 121 | QURE | uniQure N.V. | 1.46B | -5.03% | 1,215,030 | 20.17M |
| 122 | IMCR | Immunocore Holdings plc | 1.44B | -3.70% | 419,034 | 429.30M |
| 123 | RAPP | Rapport Therapeutics, Inc. | 1.41B | -4.27% | 526,320 | 20.00M |
| 124 | DMRA | Damora Therapeutics, Inc. | 1.40B | 0.29% | 395,993 | - |
| 125 | NUVB | Nuvation Bio Inc. | 1.38B | 1.56% | 5,758,369 | 201.73M |
| 126 | NTLA | Intellia Therapeutics, Inc. | 1.37B | -0.81% | 7,617,292 | 52.89M |
| 127 | ANAB | AnaptysBio, Inc. | 1.36B | -0.26% | 598,490 | 60.04M |
| 128 | TYRA | Tyra Biosciences, Inc. | 1.35B | -0.86% | 689,839 | - |
| 129 | NBTX | Nanobiotix S.A. | 1.33B | -3.82% | 107,025 | 13.15M |
| 130 | OCUL | Ocular Therapeutix, Inc. | 1.32B | 0.17% | 6,296,597 | 50.38M |
| 131 | NVAX | Novavax, Inc. | 1.31B | -1.24% | 3,550,387 | 411.65M |
| 132 | ABSI | Absci Corporation | 1.31B | 1.34% | 4,699,470 | 1.49M |
| 133 | MNKD | MannKind Corporation | 1.31B | 2.91% | 3,446,765 | 413.37M |
| 134 | LBRX | LB Pharmaceuticals Inc | 1.30B | -6.26% | 396,092 | - |
| 135 | TSHA | Taysha Gene Therapies, Inc. | 1.30B | -1.48% | 1,986,974 | 5.49M |
| 136 | GPCR | Structure Therapeutics Inc. | 1.30B | -2.15% | 583,625 | - |
| 137 | INVA | Innoviva, Inc. | 1.30B | -1.03% | 989,409 | 438.32M |
| 138 | MLYS | Mineralys Therapeutics, Inc. | 1.28B | -0.34% | 995,149 | - |
| 139 | GENB | Generate Biomedicines, Inc. | 1.27B | -6.20% | 870,693 | 21.07M |
| 140 | GHRS | GH Research PLC | 1.25B | -2.56% | 324,433 | - |
| 141 | AVLN | Avalyn Pharma Inc. | 1.24B | -6.18% | 453,013 | - |
| 142 | KARD | Kardigan, Inc. | 1.23B | 2.65% | 356,747 | - |
| 143 | SLN | Silence Therapeutics plc | 1.23B | 0.00% | 1,211,323 | 456.00K |
| 144 | NKTR | Nektar Therapeutics | 1.23B | -1.45% | 731,152 | 52.19M |
| 145 | SVRA | Savara Inc. | 1.21B | 0.34% | 3,844,092 | - |
| 146 | AAPG | Ascentage Pharma Group International | 1.20B | -1.13% | 3,059 | 94.61M |
| 147 | VOR | Vor Biopharma Inc. | 1.12B | -4.16% | 826,248 | - |
| 148 | DRTS | Alpha Tau Medical Ltd. | 1.12B | 1.00% | 1,088,632 | - |
| 149 | INBX | Inhibrx Biosciences, Inc. | 1.10B | -4.48% | 300,265 | 2.00M |
| 150 | JBIO | Jade Biosciences, Inc. | 1.07B | 0.39% | 2,078,547 | - |
| 151 | SGP | SpyGlass Pharma, Inc. | 1.05B | -2.50% | 88,099 | - |
| 152 | OMER | Omeros Corporation | 1.01B | -16.55% | 5,345,395 | 74.36M |
| 153 | ANRO | Alto Neuroscience, Inc. | 999.16M | -8.15% | 498,677 | - |
| 154 | SPTX | Seaport Therapeutics, Inc. | 972.65M | -4.97% | 278,248 | - |
| 155 | MLTX | MoonLake Immunotherapeutics | 957.45M | -4.09% | 1,185,636 | - |
| 156 | VSTM | Verastem, Inc. | 933.77M | -3.77% | 2,874,666 | 100.30M |
| 157 | ODTX | Odyssey Therapeutics, Inc. | 928.62M | 0.05% | 301,614 | 99.00K |
| 158 | LTGO | Latigo Biotherapeutics, Inc. | 912.28M | 9.21% | 661,609 | - |
| 159 | AKTS | Aktis Oncology, Inc. | 910.06M | 0.93% | 473,261 | 12.39M |
| 160 | PHAR | Pharming Group N.V. | 874.40M | -4.21% | 8,320 | 386.75M |
| 161 | CTY | City Therapeutics, Inc. | 870.74M | 3.06% | 321,270 | 14.34M |
| 162 | IMTX | Immatics N.V. | 859.78M | 1.94% | 3,164,202 | 49.33M |
| 163 | CRVS | Corvus Pharmaceuticals, Inc. | 857.87M | -4.06% | 925,974 | - |
| 164 | BBTX | Bambusa Therapeutics, Inc. | 832.91M | 2.32% | 198,254 | - |
| 165 | ORIC | ORIC Pharmaceuticals, Inc. | 829.22M | 6.38% | 1,999,944 | - |
| 166 | SNDX | Syndax Pharmaceuticals, Inc. | 828.26M | 0.77% | 2,597,940 | 289.68M |
| 167 | MGTX | MeiraGTx Holdings plc | 826.80M | -3.20% | 825,035 | 401.91M |
| 168 | RIGL | Rigel Pharmaceuticals, Inc. | 808.18M | -1.85% | 242,140 | 288.21M |
| 169 | ARDX | Ardelyx, Inc. | 799.36M | 3.58% | 4,394,320 | 468.22M |
| 170 | LXRX | Lexicon Pharmaceuticals, Inc. | 792.52M | 1.71% | 2,416,619 | 38.54M |
| 171 | GLUE | Monte Rosa Therapeutics, Inc. | 775.03M | -0.98% | 1,176,563 | 70.33M |
| 172 | IVA | Inventiva S.A. | 755.72M | -3.01% | 2,044,441 | 2.81M |
| 173 | OBX | Obsidian Therapeutics, Inc. | 745.60M | -2.35% | 282,021 | - |
| 174 | AURA | Aura Biosciences, Inc. | 744.13M | -0.97% | 627,603 | - |
| 175 | APMD | Apnimed, Inc. | 741.03M | 9.34% | 395,528 | 108.80M |
| 176 | OABI | OmniAb, Inc. | 736.59M | 3.27% | 1,263,866 | 40.21M |
| 177 | SGMT | Sagimet Biosciences Inc. | 702.97M | -2.76% | 843,498 | - |
| 178 | SLDB | Solid Biosciences Inc. | 695.33M | -3.86% | 1,133,949 | - |
| 179 | KURA | Kura Oncology, Inc. | 688.17M | 5.64% | 3,140,554 | 79.31M |
| 180 | PRME | Prime Medicine, Inc. | 685.24M | -8.35% | 4,503,951 | 7.06M |
| 181 | ATTO | Attovia Therapeutics, Inc. | 678.38M | 0.88% | 292,410 | 1.44M |
| 182 | IAM | Iambic Therapeutics, Inc. | 674.04M | 20.00% | 489,266 | 18.25M |
| 183 | QUIT | Achieve Life Sciences, Inc. | 673.41M | 0.99% | 1,097,727 | - |
| 184 | ANNX | Annexon, Inc. | 661.95M | -2.80% | 2,880,260 | - |
| 185 | NVCT | Nuvectis Pharma, Inc. | 660.27M | 0.47% | 181,014 | - |
| 186 | JANX | Janux Therapeutics, Inc. | 655.27M | -1.92% | 735,262 | 23.29M |
| 187 | GERN | Geron Corporation | 644.24M | 6.17% | 13,264,443 | 217.52M |
| 188 | BCAX | Bicara Therapeutics Inc. | 637.32M | -1.54% | 918,173 | - |
| 189 | OLMA | Olema Oncology, Inc. | 632.52M | -1.90% | 1,266,549 | - |
| 190 | DSGN | Design Therapeutics, Inc. | 630.12M | -0.81% | 294,391 | - |
| 191 | ALMS | Alumis Inc. | 628.33M | -5.84% | 1,861,053 | 7.24M |
| 192 | DBVT | DBV Technologies S.A. | 624.05M | -2.73% | 165,384 | 3.74M |
| 193 | ABUS | Arbutus Biopharma Corporation | 620.84M | 0.25% | 2,215,047 | 181.49M |
| 194 | ANL | Adlai Nortye Group Ltd. | 610.49M | -5.48% | 291,783 | 18.06M |
| 195 | FDMT | 4D Molecular Therapeutics, Inc. | 608.33M | -4.43% | 814,017 | 96.06M |
| 196 | IMMX | Immix Biopharma, Inc. | 603.45M | -3.74% | 994,012 | - |
| 197 | CGEM | Cullinan Therapeutics, Inc. | 602.14M | -2.37% | 1,626,133 | - |
| 198 | CLYM | Climb Bio, Inc. | 574.46M | -1.61% | 593,747 | - |
| 199 | SRZN | Surrozen, Inc. | 571.47M | -7.24% | 218,217 | 10.53M |
| 200 | SANA | Sana Biotechnology, Inc. | 563.31M | 0.00% | 2,632,536 | - |
| 201 | WVE | Wave Life Sciences, Inc. | 560.13M | -1.05% | 2,785,393 | 70.92M |
| 202 | ZVRA | Zevra Therapeutics, Inc. | 559.34M | 1.62% | 836,568 | 147.76M |
| 203 | CBIO | Crescent Biopharma, Inc. | 558.13M | -3.41% | 214,585 | 15.00M |
| 204 | AVBP | ArriVent BioPharma, Inc. | 552.92M | -7.53% | 863,852 | 5.00M |
| 205 | OBIO | Orchestra BioMed Holdings, Inc. | 548.57M | -2.11% | 552,135 | 31.21M |
| 206 | DNA | Ginkgo Bioworks Holdings, Inc. | 539.28M | -2.12% | 2,485,570 | 130.75M |
| 207 | ACRS | Aclaris Therapeutics, Inc. | 536.11M | -6.24% | 3,124,884 | 6.40M |
| 208 | VALN | Valneva SE | 526.59M | -1.50% | 5,982 | 163.30M |
| 209 | HELP | Helus Pharma Inc. | 526.03M | -6.13% | 3,029,375 | - |
| 210 | ETRA | Electra Therapeutics, Inc. | 524.10M | 0.48% | 332,194 | - |
| 211 | ENTX | Entera Bio Ltd. | 522.41M | -0.66% | 187,390 | 42.00K |
| 212 | INDP | Indaptus Therapeutics, Inc. | 509.89M | -3.77% | 278,498 | - |
| 213 | GYRE | Gyre Therapeutics, Inc. | 499.10M | 3.87% | 215,956 | 110.06M |
| 214 | CAPR | Capricor Therapeutics, Inc. | 488.98M | 1.33% | 4,693,636 | 11.13M |
| 215 | MNPR | Monopar Therapeutics Inc. | 481.56M | -1.26% | 126,674 | - |
| 216 | BLSM | BlossomHill Therapeutics, Inc. | 480.91M | 10.84% | 390,259 | - |
| 217 | FENC | Fennec Pharmaceuticals Inc. | 479.44M | 6.43% | 908,892 | 66.37M |
| 218 | RGNX | REGENXBIO Inc. | 478.73M | -1.09% | 963,071 | 153.91M |
| 219 | NGNE | Neurogene Inc. | 478.19M | -0.86% | 278,142 | 925.00K |
| 220 | STTK | Shattuck Labs, Inc. | 467.46M | -1.50% | 785,568 | 1.00M |
| 221 | MDXG | MiMedx Group, Inc. | 464.04M | 0.00% | 2,043,450 | 303.73M |
| 222 | OCS | Oculis Holding AG | 463.61M | -1.57% | 239,990 | 1.12M |
| 223 | ASMB | Assembly Biosciences, Inc. | 460.74M | 5.68% | 326,386 | 67.01M |
| 224 | DMAC | DiaMedica Therapeutics Inc. | 452.16M | 0.60% | 294,961 | - |
| 225 | ARVN | Arvinas, Inc. | 446.61M | 0.74% | 1,527,920 | 275.30M |
| 226 | PHAT | Phathom Pharmaceuticals, Inc. | 436.87M | -6.46% | 1,060,658 | 274.88M |
| 227 | EPRX | Eupraxia Pharmaceuticals Inc. | 436.08M | -9.81% | 1,629,506 | - |
| 228 | PRTA | Prothena Corporation plc | 424.15M | 3.64% | 596,412 | 52.74M |
| 229 | CADL | Candel Therapeutics, Inc. | 423.61M | -7.06% | 1,805,031 | - |
| 230 | CTMX | CytomX Therapeutics, Inc. | 422.93M | -2.27% | 2,147,465 | 14.03M |
| 231 | RZLT | Rezolute, Inc. | 421.19M | 12.15% | 2,889,896 | - |
| 232 | OVID | Ovid Therapeutics Inc. | 418.98M | -7.50% | 2,432,191 | 1.45M |
| 233 | AVTX | Avalo Therapeutics, Inc. | 412.28M | -3.26% | 3,133,750 | 59.00K |
| 234 | TECX | Tectonic Therapeutic, Inc. | 392.55M | -4.29% | 144,206 | - |
| 235 | IRD | Opus Genetics, Inc. | 391.45M | 0.25% | 730,825 | 7.91M |
| 236 | ALEC | Alector, Inc. | 381.13M | -0.39% | 1,269,372 | 173.47M |
| 237 | CTNM | Contineum Therapeutics, Inc. | 374.99M | -1.24% | 294,107 | - |
| 238 | CRMD | CorMedix Inc. | 371.44M | -3.11% | 1,987,742 | 412.49M |
| 239 | PBYI | Puma Biotechnology, Inc. | 369.13M | -2.72% | 593,796 | 231.83M |
| 240 | SPRY | ARS Pharmaceuticals, Inc. | 366.93M | 1.67% | 1,191,844 | 122.14M |
| 241 | MPLT | MapLight Therapeutics, Inc. | 365.13M | -4.78% | 547,760 | - |
| 242 | SLBT | SL Science Holding Limited | 362.18M | -11.73% | 60,248 | 3.27M |
| 243 | ASPE | Aspen Neuroscience, Inc. | 348.94M | -1.88% | 256,803 | - |
| 244 | PRLD | Prelude Therapeutics Incorporated | 342.83M | -2.64% | 422,307 | 21.57M |
| 245 | LYEL | Lyell Immunopharma, Inc. | 336.08M | -6.69% | 175,807 | 15.00K |
| 246 | YDES | YD Bio Limited | 335.03M | -2.07% | 35,877 | 1.24M |
| 247 | PROK | ProKidney Corp. | 332.62M | 5.77% | 1,136,243 | 775.00K |
| 248 | CCCC | C4 Therapeutics, Inc. | 332.23M | -4.53% | 3,805,622 | 32.28M |
| 249 | RLMD | Relmada Therapeutics, Inc. | 321.15M | -16.62% | 2,089,599 | - |
| 250 | AVIR | Atea Pharmaceuticals, Inc. | 318.00M | -3.88% | 448,439 | - |
| 251 | XFOR | X4 Pharmaceuticals, Inc. | 315.53M | 9.19% | 1,113,447 | 16.96M |
| 252 | LRMR | Larimar Therapeutics, Inc. | 314.35M | -0.33% | 1,379,783 | - |
| 253 | NAUT | Nautilus Biotechnology, Inc. | 300.60M | 12.38% | 4,018,191 | 424.00K |
| 254 | SCTX | Scribe Therapeutics Inc. | 298.64M | 2.60% | 272,885 | 14.83M |
| 255 | ALT | Altimmune, Inc. | 297.72M | -1.92% | 4,262,009 | 26.00K |
| 256 | KYTX | Kyverna Therapeutics, Inc. | 297.14M | -1.26% | 617,515 | - |
| 257 | BNTC | Benitec Biopharma Inc. | 294.37M | -4.57% | 175,453 | - |
| 258 | GALT | Galectin Therapeutics Inc. | 293.55M | -3.64% | 263,204 | - |
| 259 | INO | Inovio Pharmaceuticals, Inc. | 292.82M | 16.43% | 15,786,683 | 298.90K |
| 260 | AGMB | AgomAb Therapeutics NV | 291.55M | -0.84% | 296,427 | - |
| 261 | AUTL | Autolus Therapeutics plc | 290.31M | -4.39% | 2,178,000 | 137.43M |
| 262 | EVMN | Evommune, Inc. | 290.28M | -1.13% | 901,869 | 10.00M |
| 263 | VCRE | Vicore Pharma Holding AB (publ) | 287.64M | -0.39% | 2,785 | 383.48K |
| 264 | FULC | Fulcrum Therapeutics, Inc. | 286.43M | 1.08% | 1,307,236 | 80.00M |
| 265 | EDIT | Editas Medicine, Inc. | 281.67M | -2.41% | 2,103,113 | 49.83M |
| 266 | AGEN | Agenus Inc. | 280.98M | -1.27% | 859,413 | 133.95M |
| 267 | EIKN | Eikon Therapeutics, Inc. | 279.06M | -4.45% | 477,207 | - |
| 268 | IKT | Inhibikase Therapeutics, Inc. | 277.16M | -4.83% | 670,318 | 1.00 |
| 269 | GLSI | Greenwich LifeSciences, Inc. | 274.48M | 35.90% | 1,112,390 | - |
| 270 | TRXB | TRex Bio, Inc. | 269.22M | -7.15% | 270,816 | - |
| 271 | DTIL | Precision BioSciences, Inc. | 269.10M | -3.16% | 350,990 | 45.04M |
| 272 | PEPG | PepGen Inc. | 268.73M | -7.40% | 5,624,808 | - |
| 273 | SABS | SAB Biotherapeutics, Inc. | 265.76M | -1.67% | 368,217 | 114.70K |
| 274 | TTRX | Turn Therapeutics Inc. | 261.40M | 0.00% | 124,755 | - |
| 275 | QTTB | Q32 Bio Inc. | 258.24M | 4.10% | 621,720 | 53.74M |
| 276 | ALLO | Allogene Therapeutics, Inc. | 257.81M | -7.79% | 8,491,128 | 4.64M |
| 277 | OCGN | Ocugen, Inc. | 256.75M | -2.11% | 5,519,633 | 4.78M |
| 278 | ENTA | Enanta Pharmaceuticals, Inc. | 253.10M | -18.56% | 848,301 | 63.00M |
| 279 | CAMP | Camp4 Therapeutics Corporation | 251.02M | 3.63% | 216,292 | 5.32M |
| 280 | IPSC | Century Therapeutics, Inc. | 248.79M | -16.46% | 696,054 | 109.16M |
| 281 | CUVL | Clinuvel Pharmaceuticals Limited | 246.93M | -1.61% | 6,683 | 65.05M |
| 282 | PLX | Protalix BioTherapeutics, Inc. | 242.84M | -4.95% | 896,040 | 84.69M |
| 283 | LXEO | Lexeo Therapeutics, Inc. | 236.35M | -11.61% | 3,952,737 | - |
| 284 | RCKT | Rocket Pharmaceuticals, Inc. | 235.60M | -2.31% | 1,785,185 | - |
| 285 | FTH | Faeth Therapeutics, Inc. | 233.63M | -2.59% | 754,274 | - |
| 286 | VNDA | Vanda Pharmaceuticals Inc. | 230.39M | 0.00% | 830,314 | 229.28M |
| 287 | ARCT | Arcturus Therapeutics Holdings Inc. | 229.72M | -4.09% | 455,341 | 30.51M |
| 288 | BCYC | Bicycle Therapeutics plc | 224.30M | 0.63% | 445,992 | 83.53M |
| 289 | IMRX | Immuneering Corporation | 224.08M | -1.70% | 1,247,741 | - |
| 290 | KROS | Keros Therapeutics, Inc. | 221.95M | 12.76% | 423,248 | 40.76M |
| 291 | CABA | Cabaletta Bio, Inc. | 220.03M | -8.11% | 5,461,471 | - |
| 292 | VTVT | vTv Therapeutics Inc. | 215.14M | -2.26% | 26,812 | 36.84M |
| 293 | NGEN | NervGen Pharma Corp. | 210.74M | 7.69% | 1,735,275 | - |
| 294 | ACIU | AC Immune SA | 209.79M | 0.96% | 117,134 | 23.75M |
| 295 | LCTX | Lineage Cell Therapeutics, Inc. | 208.16M | 2.60% | 6,789,697 | 10.84M |
| 296 | DRUG | Bright Minds Biosciences Inc. | 202.80M | -9.29% | 180,968 | - |
| 297 | VOGX | Vogenx, Inc. | 200.25M | -6.26% | 95,013 | - |
| 298 | MDWD | MediWound Ltd. | 195.49M | 0.96% | 156,577 | 10.01M |
| 299 | CGEN | Compugen Ltd. | 191.34M | -0.98% | 197,679 | 75.93M |
| 300 | ARTV | Artiva Biotherapeutics, Inc. | 190.81M | -2.53% | 1,403,652 | 251.00K |
| 301 | RNAC | Cartesian Therapeutics, Inc. | 186.68M | 0.66% | 195,726 | 1.03M |
| 302 | WHWK | Whitehawk Therapeutics, Inc. | 181.75M | 2.33% | 489,149 | 7.15M |
| 303 | TRDA | Entrada Therapeutics, Inc. | 181.07M | -0.80% | 432,541 | 3.98M |
| 304 | PALI | Palisade Bio, Inc. | 181.07M | -1.94% | 1,970,015 | 500.00K |
| 305 | SLGL | Sol-Gel Technologies Ltd. | 172.97M | -3.88% | 63,515 | 1.44M |
| 306 | ACOG | Alpha Cognition Inc. | 172.48M | 1.15% | 121,453 | 20.20M |
| 307 | PYXS | Pyxis Oncology, Inc. | 172.24M | 2.13% | 1,435,539 | 11.04M |
| 308 | IFRX | InflaRx N.V. | 169.47M | -2.54% | 1,987,444 | -38.53K |
| 309 | KRRO | Korro Bio, Inc. | 169.10M | -3.07% | 158,227 | 1.29M |
| 310 | ORMP | Oramed Pharmaceuticals Inc. | 168.29M | -0.77% | 186,363 | 2.00M |
| 311 | ELDN | Eledon Pharmaceuticals, Inc. | 167.39M | 0.51% | 1,040,686 | - |
| 312 | PRQR | ProQR Therapeutics N.V. | 162.29M | -2.54% | 1,163,228 | 23.46M |
| 313 | ANTX | AN2 Therapeutics, Inc. | 160.50M | -5.37% | 285,651 | - |
| 314 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 155.54M | -2.02% | 375,900 | - |
| 315 | IVVD | Invivyd, Inc. | 151.54M | -4.67% | 6,914,095 | 60.69M |
| 316 | ABEO | Abeona Therapeutics Inc. | 148.58M | 0.00% | 1,710,300 | 39.01M |
| 317 | STRO | Sutro Biopharma, Inc. | 148.08M | -4.29% | 210,428 | 45.11M |
| 318 | VRXA | Veraxa Biotech AG | 147.06M | -0.48% | 111,524 | 29.54K |
| 319 | ZNTL | Zentalis Pharmaceuticals, Inc. | 146.42M | -6.88% | 1,296,049 | 26.87M |
| 320 | TARA | Protara Therapeutics, Inc. | 142.84M | -2.52% | 726,073 | - |
| 321 | RNA | Atrium Therapeutics, Inc. | 139.78M | 0.78% | 352,108 | 38.82M |
| 322 | HUMA | Humacyte, Inc. | 139.18M | -7.27% | 4,345,445 | 2.40M |
| 323 | ALXO | ALX Oncology Holdings Inc. | 138.97M | 0.50% | 438,382 | - |
| 324 | SION | Sionna Therapeutics, Inc. | 138.87M | -1.60% | 553,484 | - |
| 325 | MENS | Jyong Biotech Ltd. | 133.62M | 1.69% | 16,422 | - |
| 326 | PYPD | PolyPid Ltd. | 132.84M | 6.34% | 772,585 | - |
| 327 | YARW | Yarrow Bioscience, Inc. | 132.21M | 2.01% | 135,651 | - |
| 328 | MSLE | Satellos Bioscience Inc. | 131.57M | -4.17% | 38,239 | - |
| 329 | MGNX | MacroGenics, Inc. | 131.01M | -5.53% | 572,900 | 140.81M |
| 330 | FATE | Fate Therapeutics, Inc. | 124.00M | -10.53% | 2,438,962 | 4.75M |
| 331 | NTHI | NeOnc Technologies Holdings, Inc. | 120.25M | -4.63% | 264,232 | 39.99K |
| 332 | IPHA | Innate Pharma S.A. | 117.84M | -5.34% | 95,462 | 11.21M |
| 333 | CDXS | Codexis, Inc. | 117.27M | 0.94% | 1,143,408 | 88.34M |
| 334 | SPRB | Spruce Biosciences, Inc. | 116.37M | -4.17% | 152,632 | 697.00K |
| 335 | ENGN | enGene Therapeutics Inc. | 115.27M | -8.99% | 1,730,243 | - |
| 336 | CNTN | Canton Strategic Holdings, Inc. | 115.17M | -13.41% | 1,111,025 | 4.47M |
| 337 | UPB | Upstream Bio, Inc. | 115.10M | -2.33% | 1,182,801 | 2.87M |
| 338 | LENZ | LENZ Therapeutics, Inc. | 109.97M | -8.38% | 775,335 | 12.36M |
| 339 | FHTX | Foghorn Therapeutics Inc. | 109.73M | 2.23% | 1,762,328 | 112.13M |
| 340 | CMPX | Compass Therapeutics, Inc. | 109.26M | -8.28% | 2,903,506 | 850.00K |
| 341 | UNCY | Unicycive Therapeutics, Inc. | 107.98M | 0.00% | 1,120,705 | - |
| 342 | NERV | Minerva Neurosciences, Inc. | 107.64M | -1.82% | 151,379 | - |
| 343 | MOLN | Molecular Partners AG | 107.43M | 5.97% | 2,386 | 856.30K |
| 344 | CBUS | Cibus, Inc. | 106.24M | 15.83% | 715,314 | 4.53M |
| 345 | NRXP | NRx Pharmaceuticals, Inc. | 105.99M | 13.95% | 1,596,692 | 4.31M |
| 346 | OKUR | OnKure Therapeutics, Inc. | 104.50M | -6.18% | 228,165 | - |
| 347 | ICCC | ImmuCell Corporation | 102.90M | -0.79% | 18,535 | 33.21M |
| 348 | IMUX | Immunic, Inc. | 100.01M | 1.38% | 141,515 | - |
| 349 | ZURA | Zura Bio Limited | 99.70M | -4.17% | 3,525,295 | - |
| 350 | ADAG | Adagene Inc. | 99.37M | -7.50% | 2,338,431 | 9.29M |
| 351 | ARMP | Armata Pharmaceuticals, Inc. | 98.93M | -11.04% | 238,973 | 7.56M |
| 352 | NBP | NovaBridge Biosciences | 95.39M | 3.89% | 858,477 | - |
| 353 | RTSN | Retension Pharmaceuticals, Inc. | 95.06M | -0.44% | 44,129 | - |
| 354 | EQ | Equillium, Inc. | 94.82M | 5.22% | 619,998 | 4.39M |
| 355 | VANI | Vivani Medical, Inc. | 94.71M | 2.94% | 259,968 | - |
| 356 | VYGR | Voyager Therapeutics, Inc. | 94.59M | -6.75% | 991,492 | 25.11M |
| 357 | ANIX | Anixa Biosciences, Inc. | 92.82M | 4.71% | 228,036 | - |
| 358 | PMVP | PMV Pharmaceuticals, Inc. | 92.13M | 2.52% | 720,337 | - |
| 359 | NKTX | Nkarta, Inc. | 89.63M | 3.31% | 1,043,829 | - |
| 360 | GNLX | Genelux Corporation | 89.62M | 4.17% | 251,778 | 8.00K |
| 361 | TVGN | Tevogen Inc. | 89.54M | -8.52% | 2,133 | - |
| 362 | HURA | TuHURA Biosciences, Inc. | 89.22M | 5.26% | 647,254 | - |
| 363 | OTLK | Outlook Therapeutics, Inc. | 87.79M | -8.94% | 5,300,068 | -1.16M |
| 364 | TLSA | Tiziana Life Sciences Ltd | 82.96M | 12.46% | 742,773 | - |
| 365 | BDTX | Black Diamond Therapeutics, Inc. | 82.75M | -5.88% | 660,324 | 70.00M |
| 366 | RLYB | Rallybio Corporation | 82.32M | -0.91% | 44,031 | 434.00K |
| 367 | CLLS | Cellectis S.A. | 81.56M | 1.92% | 21,038 | 32.10M |
| 368 | SEER | Seer, Inc. | 80.84M | -1.35% | 171,473 | 14.08M |
| 369 | PLYX | Polaryx Therapeutics, Inc. | 79.75M | -4.19% | 30,656 | - |
| 370 | RANI | Rani Therapeutics Holdings, Inc. | 78.01M | 3.54% | 630,158 | 6.58M |
| 371 | MAIA | MAIA Biotechnology, Inc. | 77.19M | 23.76% | 1,928,946 | - |
| 372 | TENX | Tenax Therapeutics, Inc. | 76.12M | -4.05% | 1,154,390 | - |
| 373 | CHRS | Coherus Oncology, Inc. | 73.95M | -5.42% | 3,277,306 | 53.64M |
| 374 | TNYA | Tenaya Therapeutics, Inc. | 73.58M | -3.24% | 5,467,712 | 3.03M |
| 375 | KZIA | Kazia Therapeutics Limited | 72.77M | -5.18% | 650,754 | 1.27M |
| 376 | COYA | Coya Therapeutics, Inc. | 70.84M | 0.67% | 131,241 | 4.69M |
| 377 | CING | Cingulate Inc. | 68.64M | 25.87% | 1,626,825 | - |
| 378 | AVXL | Anavex Life Sciences Corp. | 68.60M | -9.49% | 2,272,004 | - |
| 379 | NTRB | Nutriband Inc. | 67.95M | -3.79% | 20,573 | 1.62M |
| 380 | GOSS | Gossamer Bio, Inc. | 67.52M | 0.55% | 221,621 | 78.42M |
| 381 | MNOV | MediciNova, Inc. | 65.96M | 0.00% | 58,324 | 935.72K |
| 382 | CRDF | Cardiff Oncology, Inc. | 65.85M | -0.15% | 1,995,301 | 559.00K |
| 383 | NRXS | NeurAxis, Inc. | 65.43M | -3.96% | 212,308 | 6.53M |
| 384 | ATRA | Atara Biotherapeutics, Inc. | 65.25M | 1.56% | 71,803 | 3.97M |
| 385 | PDSB | PDS Biotechnology Corporation | 64.78M | -3.28% | 3,565,588 | - |
| 386 | CSBR | Champions Oncology, Inc. | 63.91M | -1.89% | 4,845 | 60.66M |
| 387 | NMRA | Neumora Therapeutics, Inc. | 62.85M | -9.47% | 1,798,781 | - |
| 388 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 62.03M | -10.81% | 570,658 | - |
| 389 | CNXU | Conexeu Sciences Inc. | 61.66M | -9.50% | 196,531 | - |
| 390 | ACRV | Acrivon Therapeutics, Inc. | 61.28M | -2.05% | 428,288 | - |
| 391 | FBIO | Fortress Biotech, Inc. | 60.70M | 6.43% | 434,442 | 69.99M |
| 392 | CGTX | Cognition Therapeutics, Inc. | 59.90M | -1.39% | 452,570 | - |
| 393 | MIST | Milestone Pharmaceuticals Inc. | 58.22M | 13.21% | 5,591,048 | 5.31M |
| 394 | OKYO | OKYO Pharma Limited | 57.99M | -5.96% | 167,375 | - |
| 395 | TNXP | Tonix Pharmaceuticals Holding Corp. | 57.13M | 2.08% | 743,829 | 43.05M |
| 396 | BOLD | Boundless Bio, Inc. | 54.82M | 0.00% | 106,039 | - |
| 397 | XBIT | XBiotech Inc. | 54.27M | -3.78% | 62,583 | - |
| 398 | VRCA | Verrica Pharmaceuticals Inc. | 53.94M | -1.88% | 97,232 | 22.89M |
| 399 | NORD | Nordicus Partners Corporation | 53.83M | -3.83% | 9,670 | - |
| 400 | HRTX | Heron Therapeutics, Inc. | 53.70M | -0.74% | 2,658,079 | 148.22M |
| 401 | IBO | Impact BioMedical Inc. | 53.31M | 25.66% | 25,481 | 38.00K |
| 402 | SPRO | Spero Therapeutics, Inc. | 52.49M | -4.77% | 332,463 | 41.56M |
| 403 | AZR | Azora Therapeutics, Inc. | 52.36M | -3.81% | 47,840 | - |
| 404 | GANX | Gain Therapeutics, Inc. | 51.50M | 25.51% | 4,310,888 | - |
| 405 | HOWL | Werewolf Therapeutics, Inc. | 51.03M | 5.97% | 1,083,148 | 21.00M |
| 406 | RNXT | RenovoRx, Inc. | 50.18M | 8.91% | 493,242 | 2.78M |
| 407 | XLO | Xilio Therapeutics, Inc. | 49.61M | -2.08% | 6,252 | 55.01M |
| 408 | ONCY | Oncolytics Biotech Inc. | 48.77M | 12.53% | 1,587,161 | - |
| 409 | IBIO | iBio, Inc. | 48.11M | 5.86% | 533,827 | 1.08M |
| 410 | ELOX | Eloxx Pharmaceuticals, Inc. | 47.39M | -7.92% | 32,224 | - |
| 411 | INKT | MiNK Therapeutics, Inc. | 47.38M | -0.70% | 28,149 | 200.00K |
| 412 | CLNN | Clene Inc. | 46.37M | -12.02% | 204,947 | 238.00K |
| 413 | ANVS | Annovis Bio, Inc. | 46.10M | -0.91% | 1,888,325 | - |
| 414 | IMA | ImageneBio, Inc. | 44.27M | 21.87% | 90,383 | 800.00K |
| 415 | MREO | Mereo BioPharma Group plc | 43.84M | -10.00% | 1,037,965 | 800.00K |
| 416 | HYFT | MindWalk Holdings Corp. | 42.72M | -3.32% | 242,387 | 11.57M |
| 417 | ATNM | Actinium Pharmaceuticals, Inc. | 42.45M | -9.40% | 555,005 | 35.00M |
| 418 | ALDX | Aldeyra Therapeutics, Inc. | 41.88M | 3.63% | 743,908 | - |
| 419 | DWTX | Dogwood Therapeutics, Inc. | 41.29M | 1.89% | 144,190 | 100.00K |
| 420 | PLRX | Pliant Therapeutics, Inc. | 40.88M | -4.76% | 787,556 | - |
| 421 | ELTX | Elicio Therapeutics, Inc. | 40.48M | -3.38% | 449,262 | - |
| 422 | IRLA | IRulya Therapeutics Inc. | 39.11M | 2.92% | 139,626 | - |
| 423 | ALPS | Alps Group Inc | 38.94M | 1.74% | 28,750 | 3.74M |
| 424 | APLM | Apollomics, Inc. | 37.30M | -5.61% | 9,592 | 445.00K |
| 425 | HYPD | Hyperion DeFi, Inc. | 36.98M | -3.64% | 88,951 | 1.91M |
| 426 | CRBU | Caribou Biosciences, Inc. | 36.81M | -3.43% | 2,566,359 | 9.44M |
| 427 | TIL | Instil Bio, Inc. | 36.62M | -6.09% | 164,635 | - |
| 428 | VERU | Veru Inc. | 36.49M | 2.88% | 304,993 | 16.89M |
| 429 | CNTB | Connect Biopharma Holdings Limited | 36.45M | -9.98% | 957,396 | 3.67M |
| 430 | GRCE | Grace Therapeutics, Inc. | 36.18M | -1.71% | 189,070 | - |
| 431 | BMEA | Biomea Fusion, Inc. | 35.37M | -6.17% | 1,200,006 | - |
| 432 | SER | Serina Therapeutics, Inc. | 34.67M | -3.87% | 28,436 | 125.00K |
| 433 | OSTX | OS Therapies Incorporated | 34.41M | 9.42% | 1,163,713 | - |
| 434 | KLRS | Kalaris Therapeutics, Inc. | 34.04M | -2.05% | 252,572 | - |
| 435 | EYPT | EyePoint, Inc. | 33.67M | -3.80% | 4,576,286 | 2.58M |
| 436 | ATHE | Alterity Therapeutics Limited | 33.22M | -4.85% | 69,188 | 2.50M |
| 437 | CVM | CEL-SCI Corporation | 32.54M | 11.45% | 1,489,068 | - |
| 438 | TELO | Telomir Pharmaceuticals, Inc. | 31.17M | -12.04% | 326,170 | - |
| 439 | RNTX | Rein Therapeutics Inc. | 30.75M | -10.90% | 2,484,299 | - |
| 440 | EXOZ | eXoZymes, Inc. | 30.72M | -17.04% | 15,068 | -700.00 |
| 441 | NXTC | NextCure, Inc. | 30.67M | 0.30% | 78,011 | - |
| 442 | BCTX | BriaCell Therapeutics Corp. | 30.27M | 6.36% | 117,299 | - |
| 443 | ACET | Adicet Bio, Inc. | 29.93M | 1.09% | 389,660 | - |
| 444 | INMB | INmune Bio Inc. | 29.72M | 1.44% | 620,387 | 50.00K |
| 445 | NNVC | NanoViricides, Inc. | 29.61M | -6.45% | 252,826 | - |
| 446 | PMN | ProMIS Neurosciences, Inc. | 28.79M | -3.02% | 145,511 | - |
| 447 | EDSA | Edesa Biotech, Inc. | 26.48M | 3.70% | 326,752 | - |
| 448 | PTHS | Pelthos Therapeutics Inc. | 26.19M | -4.34% | 74,257 | 51.29M |
| 449 | LONA | LeonaBio, Inc. | 26.00M | -14.55% | 24,616 | - |
| 450 | PLRZ | Polyrizon Ltd. | 25.86M | -0.47% | 15,648 | - |
| 451 | EVAX | Evaxion A/S | 25.64M | 0.36% | 34,700 | 7.49M |
| 452 | AARD | Aardvark Therapeutics, Inc. | 25.17M | -8.73% | 475,500 | - |
| 453 | ABVC | ABVC BioPharma, Inc. | 24.41M | 0.00% | 24,345 | 797.92K |
| 454 | FLNA | Filana Therapeutics, Inc. | 24.17M | 2.32% | 542,487 | - |
| 455 | RNAZ | TransCode Therapeutics, Inc. | 23.87M | 4.44% | 36,400 | - |
| 456 | IMMP | Immutep Limited | 23.85M | -4.12% | 6,813 | 13.79M |
| 457 | MGX | Metagenomi Therapeutics, Inc. | 23.84M | -7.21% | 177,884 | 7.09M |
| 458 | LITS | Lite Strategy, Inc. | 23.75M | -7.20% | 267,940 | - |
| 459 | GRDX | GridAI Technologies Corp. | 23.37M | 0.00% | 314,840 | - |
| 460 | BYSI | BeyondSpring Inc. | 23.02M | -3.27% | 13,612 | 1.88M |
| 461 | CRVO | CervoMed Inc. | 22.69M | -10.18% | 356,905 | 8.73K |
| 462 | IGC | IGC Pharma, Inc. | 21.93M | 7.37% | 376,807 | 1.11M |
| 463 | CUE | Cue Biopharma, Inc. | 20.56M | -79.93% | 4,229,479 | 35.64M |
| 464 | COCP | Cocrystal Pharma, Inc. | 19.46M | 3.30% | 40,554 | 435.00K |
| 465 | ATOS | Atossa Therapeutics, Inc. | 18.96M | -1.55% | 46,392 | - |
| 466 | CELU | Celularity Inc. | 18.53M | -7.75% | 229,541 | 18.67M |
| 467 | LPCN | Lipocine Inc. | 17.72M | -3.61% | 71,957 | 3.74M |
| 468 | BSEM | BioStem Technologies, Inc. | 17.38M | -2.61% | 241,490 | 31.75M |
| 469 | ABOS | Acumen Pharmaceuticals, Inc. | 16.64M | 6.53% | 2,689,851 | - |
| 470 | QNRX | Quoin Pharmaceuticals, Ltd. | 16.14M | -5.62% | 8,316 | - |
| 471 | CNTX | Context Therapeutics Inc. | 15.71M | 3.07% | 2,036,699 | - |
| 472 | NCEL | NewcelX Ltd. | 15.48M | -2.55% | 7,662 | - |
| 473 | KTTA | Pasithea Therapeutics Corp. | 14.51M | -13.14% | 2,079,830 | - |
| 474 | ESLA | Estrella Immunopharma, Inc. | 14.42M | -12.74% | 747,761 | - |
| 475 | MCRB | Seres Therapeutics, Inc. | 14.37M | 0.00% | 55,575 | 2.13M |
| 476 | CTXR | Citius Pharmaceuticals, Inc. | 14.24M | -1.67% | 117,023 | 7.11M |
| 477 | MRKR | Marker Therapeutics, Inc. | 13.95M | 0.97% | 203,051 | 2.31M |
| 478 | QNTM | Quantum BioPharma Ltd. | 13.93M | 10.42% | 179,832 | - |
| 479 | ACTU | Actuate Therapeutics, Inc. | 13.84M | -6.12% | 194,067 | - |
| 480 | PASG | Passage Bio, Inc. | 13.58M | 2.18% | 24,651 | - |
| 481 | TVRD | Tvardi Therapeutics, Inc. | 13.47M | -8.18% | 71,330 | - |
| 482 | ALLR | Allarity Therapeutics, Inc. | 13.38M | -3.91% | 214,300 | 350.00K |
| 483 | AKTX | Akari Therapeutics, Plc | 13.03M | -12.44% | 11,458 | - |
| 484 | GUTS | Fractyl Health, Inc. | 12.81M | -2.66% | 232,359 | 3.00K |
| 485 | ATYR | aTyr Pharma, Inc. | 12.72M | -4.77% | 125,274 | 190.00K |
| 486 | NEUP | Neuphoria Therapeutics Inc. | 12.28M | -8.47% | 33,724 | 1.17M |
| 487 | PLUR | Pluri Inc. | 12.10M | -5.77% | 25,600 | 1.46M |
| 488 | BCDA | BioCardia, Inc. | 11.93M | -0.24% | 41,869 | 3.00K |
| 489 | CMMB | Chemomab Therapeutics Ltd. | 11.88M | 1.23% | 166,111 | - |
| 490 | DYAI | Dyadic International, Inc. | 11.51M | -1.25% | 44,133 | 3.09M |
| 491 | JSPR | Jasper Therapeutics, Inc. | 11.47M | -12.15% | 49,022 | - |
| 492 | BOLT | Bolt Biotherapeutics, Inc. | 11.11M | -2.59% | 86,643 | 4.70M |
| 493 | HIND | Vyome Holdings, Inc. | 10.84M | 0.98% | 6,419 | 153.10K |
| 494 | PPBT | Purple Biotech Ltd | 10.67M | 1.79% | 15,210 | - |
| 495 | BIVI | BioVie Inc. | 10.67M | -7.84% | 441,032 | - |
| 496 | TCRX | TScan Therapeutics, Inc. | 10.23M | 4.07% | 310,648 | 5.19M |
| 497 | PBM | Psyence Biomedical Ltd. | 9.57M | -11.31% | 65,335 | - |
| 498 | LSTA | Lisata Therapeutics, Inc. | 9.37M | -4.59% | 246,912 | 100.00K |
| 499 | GDTC | CytoMed Therapeutics Limited | 9.35M | 1.18% | 19,228 | 609.73K |
| 500 | BLRX | BioLineRx Ltd. | 8.97M | -2.61% | 33,180 | 1.39M |